Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Anita Saraf
- Study ID
- NCT06260059
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Adult Congenital Heart Disease
- Heart Failure
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Empagliflozin 10 MG — DRUGPatient will be given 10 mg of Empagliflozin if randomized to the drug arm or will receive placebo drug for 1 year
- Placebo — DRUGTo patients randomized to the placebo group, a placebo pill will be given
Study Details
The goal of the study is to investigate the feasibility and benefit of novel guideline-directed heart failure therapy drug Empagliflozin (Jardiance) for adult patients with congenital heart disease (ACHD).
Key Dates
- Start date
- Sep 17, 2024
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2026
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Empagliflozin 10 MGEmpagliflozin 10 mg daily will be administered for 1 year. The patient and the PI will be blinded (unaware) of the group they are assigned to.
- Placebo Comparator: PlaceboPlacebo for 1 year
Primary Outcome Measure
Change in Ejection fraction (EF) [ Time Frame: Change from baseline in ejection fraction at 1-year ]
Central Contacts
- Anita Saraf, MD, PhD4128648661
- Morgan Hindes
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | Anita Saraf, MD,PhD |
| Magee Women's Hospital | Pittsburgh | Pennsylvania | 15213 | Anita Saraf, MD, PhD |
| Presbyterian Hospital | Pittsburgh | Pennsylvania | 15213 | Anita Saraf, MD, PhD |
Find similar trials in Pittsburgh, PA
By condition
By specialty
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- Global Utilization And Registry Database for Improved heArt preservatioNEnrolling By Invitation · Paragonix Technologies · Stanford, California